BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30772497)

  • 1. STING-associated lung disease in mice relies on T cells but not type I interferon.
    Luksch H; Stinson WA; Platt DJ; Qian W; Kalugotla G; Miner CA; Bennion BG; Gerbaulet A; Rösen-Wolff A; Miner JJ
    J Allergy Clin Immunol; 2019 Jul; 144(1):254-266.e8. PubMed ID: 30772497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
    Siedel H; Roers A; Rösen-Wolff A; Luksch H
    Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING-associated vasculopathy develops independently of IRF3 in mice.
    Warner JD; Irizarry-Caro RA; Bennion BG; Ai TL; Smith AM; Miner CA; Sakai T; Gonugunta VK; Wu J; Platt DJ; Yan N; Miner JJ
    J Exp Med; 2017 Nov; 214(11):3279-3292. PubMed ID: 28951494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
    Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
    Liang L; Shen Y; Hu Y; Liu H; Cao J
    PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
    Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
    J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice.
    Stinson WA; Miner CA; Zhao FR; Lundgren AJ; Poddar S; Miner JJ
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 36073546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.
    Motwani M; Pawaria S; Bernier J; Moses S; Henry K; Fang T; Burkly L; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7941-7950. PubMed ID: 30944222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GRA15 protein from
    Wang P; Li S; Zhao Y; Zhang B; Li Y; Liu S; Du H; Cao L; Ou M; Ye X; Li P; Gao X; Wang P; Jing C; Shao F; Yang G; You F
    J Biol Chem; 2019 Nov; 294(45):16494-16508. PubMed ID: 31416833
    [No Abstract]   [Full Text] [Related]  

  • 11. Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure.
    Gram AM; Sun C; Landman SL; Oosenbrug T; Koppejan HJ; Kwakkenbos MJ; Hoeben RC; Paludan SR; Ressing ME
    Mol Immunol; 2017 Nov; 91():225-237. PubMed ID: 28968560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STING agonism turns human T cells into interferon-producing cells but impedes their functionality.
    Kuhl N; Linder A; Philipp N; Nixdorf D; Fischer H; Veth S; Kuut G; Xu TT; Theurich S; Carell T; Subklewe M; Hornung V
    EMBO Rep; 2023 Mar; 24(3):e55536. PubMed ID: 36705069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Cell Intrinsic STING Signaling Is Not Required for Autoreactive Germinal Center Participation.
    Green K; Wittenborn TR; Fahlquist-Hagert C; Terczynska-Dyla E; van Campen N; Jensen L; Reinert L; Hartmann R; Paludan SR; Degn SE
    Front Immunol; 2021; 12():782558. PubMed ID: 34938294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
    Berthelot JM; Lioté F; Maugars Y; Sibilia J
    Front Immunol; 2020; 11():607069. PubMed ID: 33335532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine delta papillomavirus E5 oncoprotein negatively regulates the cGAS-STING signaling pathway in cattle in a spontaneous model of viral disease.
    De Falco F; Cutarelli A; Catoi AF; Uberti BD; Cuccaro B; Roperto S
    Front Immunol; 2022; 13():937736. PubMed ID: 36311756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cGAS/STING/TBK1/IRF3 Signaling Pathway Activates BMDCs Maturation Following
    Li Q; Liu C; Yue R; El-Ashram S; Wang J; He X; Zhao D; Zhou X; Xu L
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic d-type CpG-oligonucleotides induce a type I interferon response by activating the cGAS-STING signaling pathway.
    Bode C; Poth JM; Fox M; Schulz S; Klinman DM; Latz E; Steinhagen F
    Eur J Immunol; 2021 Jul; 51(7):1686-1697. PubMed ID: 33860535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
    Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
    Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-1 interferon-dependent and -independent mechanisms in cyclic GMP-AMP synthase-stimulator of interferon genes-driven auto-inflammation.
    Gao KM; Marshak-Rothstein A; Fitzgerald KA
    Curr Opin Immunol; 2023 Feb; 80():102280. PubMed ID: 36638547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.